India To Cancel License Of China's Chongiqing Daxin After Visit Denial
This article was originally published in PharmAsia News
Executive Summary
Indian authorities said they would cancel the registration certificate of China's Chongiqing Daxin Pharmaceutical because it denied access to inspectors